From: Relation between FCGRIIB rs1050501 and HSV-1 specific IgG antibodies in Alzheimer’s disease
FCGRIIB rs1050501 genotypes (%) | HSV-1 Ab IgG (AI) | HSV-1 IgG1 (OD) | HSV-1 IgG2 (OD) | HSV-1 IgG3 (OD) | HSV-1 IgG4 (OD) | |
---|---|---|---|---|---|---|
AD (no 69) | TT (74.2) | 8.94; 7.17–10.50 | 2.06; 1.47–2.56 | 0.95; 0.76–1.14 | 0.65; 0.49–0.78 | 0.59; 0.58–0.72 |
CT (22.7) | 8.78; 7.22–9.33 | 2.23; 1.13–2.44 | 0.75; 0.75–0.75 | 0.69; 0.49–0.86 | 0.58; 0.57–1.38 | |
CC (3.1) | 7.60; 5.5–9.71 | 3.18; 3.18–3.18 | – | 0.46; 0.46–0.46 | – | |
MCI (no 52) | TT (74.5) | 8.82; 7.1–10.96 | 2.03; 1.68–2.60 | 0.66; 0.53-0.80 | 0.75; 0.47-0.95 | 0.58; 0.56–0.82 |
CT (21.6) | 8.03; 5.25–10.99 | 2.31; 2.02–3.07 | – | 0.61; 0.48–0.77 | 0.6; 0.57–1.04 | |
CC (3.9) | 10.77; 8.85–12.7 | 2.29; 1.99–2.59 | – | 0.44; 0.42–0.47 | – | |
HC (no 49) | TT (79.2) | 7.53; 6.12–8.83 | 2.56; 1.98–2.99 | – | 0.62; 0.53–0.72 | 0.58; 0.54–1.81 |
CT (18.7) | 6.29; 5.60–7.74 | 2.46; 1.49–2.94 | – | 0.89; 0.36–1.17 | 1.02; 0.68–1.48 | |
CC (2.1) | 7.47; 7.47–7.47 | 3.12; 3.12–3.12 | – | – | 0.55; 0.55–0.55 |